Cargando…
Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Japan
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741781/ https://www.ncbi.nlm.nih.gov/pubmed/29159517 http://dx.doi.org/10.1007/s12282-017-0815-7 |
| _version_ | 1783288249400164352 |
|---|---|
| author | Hattori, Masaya Ishiguro, Hiroshi Masuda, Norikazu Yoshimura, Akiyo Ohtani, Shoichiro Yasojima, Hiroyuki Morita, Satoshi Ohno, Shinji Iwata, Hiroji |
| author_facet | Hattori, Masaya Ishiguro, Hiroshi Masuda, Norikazu Yoshimura, Akiyo Ohtani, Shoichiro Yasojima, Hiroyuki Morita, Satoshi Ohno, Shinji Iwata, Hiroji |
| author_sort | Hattori, Masaya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5741781 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Japan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57417812018-01-04 Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study Hattori, Masaya Ishiguro, Hiroshi Masuda, Norikazu Yoshimura, Akiyo Ohtani, Shoichiro Yasojima, Hiroyuki Morita, Satoshi Ohno, Shinji Iwata, Hiroji Breast Cancer Correction Springer Japan 2017-11-20 2018 /pmc/articles/PMC5741781/ /pubmed/29159517 http://dx.doi.org/10.1007/s12282-017-0815-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Hattori, Masaya Ishiguro, Hiroshi Masuda, Norikazu Yoshimura, Akiyo Ohtani, Shoichiro Yasojima, Hiroyuki Morita, Satoshi Ohno, Shinji Iwata, Hiroji Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study |
| title | Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study |
| title_full | Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study |
| title_fullStr | Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study |
| title_full_unstemmed | Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study |
| title_short | Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study |
| title_sort | correction to: phase i dose-finding study of eribulin and capecitabine for metastatic breast cancer: jbcrg-18 cape study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741781/ https://www.ncbi.nlm.nih.gov/pubmed/29159517 http://dx.doi.org/10.1007/s12282-017-0815-7 |
| work_keys_str_mv | AT hattorimasaya correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy AT ishigurohiroshi correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy AT masudanorikazu correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy AT yoshimuraakiyo correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy AT ohtanishoichiro correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy AT yasojimahiroyuki correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy AT moritasatoshi correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy AT ohnoshinji correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy AT iwatahiroji correctiontophaseidosefindingstudyoferibulinandcapecitabineformetastaticbreastcancerjbcrg18capestudy |